Single-cell transcriptomic analysis reveals novel lncRNA macromolecules associated with PARP11, LMF1, and RRM2

Ali Haider1, Rahman Ud Din1, Bushra Habib2

  • 1Department of Biomedical Engineering, College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China.

Insights

This study reveals novel long non-coding RNAs (lncRNAs) in lung cancer, uncovering their role in tumor evolution and immune suppression. A new tool, lncScape, aids in analyzing these crucial lncRNA macromolecules.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Lung cancer is a leading cause of mortality, characterized by complex tumor heterogeneity and immune microenvironments.
  • Understanding the role of long non-coding RNAs (lncRNAs) in non-small cell lung cancer (NSCLC) is crucial for developing new therapies.
  • Existing research has gaps in characterizing lncRNA involvement in NSCLC's molecular landscape.

Purpose of the Study:

  • To investigate the role of lncRNA macromolecules in NSCLC heterogeneity using single-cell RNA sequencing (scRNA-seq).
  • To identify novel lncRNA markers and their associated molecular pathways in NSCLC.
  • To develop a user-friendly platform for integrative lncRNA analysis in single-cell data.

Main Methods:

  • Integrative single-cell RNA sequencing (scRNA-seq) analysis of NSCLC samples.
  • Unsupervised clustering and differential expression analysis to identify cell populations and markers.
  • Quantitative real-time PCR (qRT-PCR) for experimental validation of lncRNA expression.
  • Pseudotime trajectory modeling and transcription factor-pathway association analysis.
  • Development of the open-source Shiny application, lncScape, for lncRNA analysis.

Main Results:

  • Identified distinct immune and malignant cell populations in NSCLC.
  • Discovered novel lncRNAs (AC005842.1, AC009041.2, AC007240.1) enriched in specific tumor and immune subsets.
  • Linked lncRNAs to key cancer pathways such as epithelial-mesenchymal transition (EMT), hypoxia, and immune modulation.
  • Confirmed lncRNA upregulation and EMT activation via qRT-PCR.
  • Uncovered dynamic activation of TNFA-NFκB and IL2-STAT5 signaling, indicating immune suppression and metabolic reprogramming.
  • Identified novel transcription factor-pathway associations (NR5A1-OXPHOS, FOXA2-mTORC1).

Conclusions:

  • This study enhances the understanding of lncRNA macromolecules in lung cancer pathogenesis and immune evasion.
  • The identified lncRNAs and pathways offer potential therapeutic targets for NSCLC.
  • The developed lncScape platform provides a valuable resource for future lncRNA-centric research in single-cell genomics.